Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation | MicrobiomeTrials← Back to trialsNCT07414225
Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2030-02-25
Enrollment target: 400 participants Locations- Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Atrial Fibrillation (AF)Mitral Valve (MV) Regurgitation
CABA-MiTRA-AFNET12 is a non-commercial, parallel-group, prospective, randomised, open, blinded endpoint assessment (PROB…
Cologne, GermanyEst. completion Sep 1, 2031
Mitral Valve Regurgitation
This is a prospective, multicenter, open-label, randomized trial comparing mitral valve (MV) transcatheter edge-to-edge …
Los Angeles, United StatesEst. completion Jun 30, 2029